Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Idec reports 1Q results after the market closes, Wall Street focuses on MS drugs
Biogen Idec reports 1Q results after the market closes, Wall Street focuses on MS drugs
Biogen Idec reports 1Q results after the market closes, Wall Street focuses on MS drugs
Submitted by
admin
on April 16, 2009 - 7:55am
Source:
Yahoo/AP
News Tags:
Biogen Idec
earnings
MS
multiple sclerosis
Tysabri
Headline:
Biogen Idec reports 1Q results after the market closes, Wall Street focuses on MS drugs
Do Not Allow Advertisers to Use My Personal information
